Tokyo, May 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061608) titled 'Usefulness of Human papillomavirus (HPV) prevention educational materials for parents of adolescent boys' on May 18.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Ishikawa Prefectural Nursing University
Condition:
Condition - HPV-related disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the usefulness of a storytelling-based educational material for parents for the prevention of HPV-related diseases, in terms of its effects on their intention to recommend HPV vaccination to their sons, factors associated with that intention, acceptability of the material, and feasibility of implementation.
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - Web-based delivery of a storytelling-based educational material for prevention of HPV-related diseases
Eligibility:
Age-lower limit - 30
years-old
=
Gender - Male and Female
Key inclusion criteria - 1.Residents of areas that provide subsidy for HPV vaccination for adolescent boys.
2.Fathers or mothers aged 30-55 years who have a son born in fiscal years 2009-2013.
Key exclusion criteria - 1.Parents who have a son born before fiscal year 2009.
2.Parents who have a daughter born before fiscal year 2013.
3.Individuals engaged in mass media, advertising, or market research.
4.Parents whose son's HPV vaccination status is vaccinated, unknown, or who refused to answer.
Target Size - 138
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2025 Year 09 Month 05 Day
Date of IRB - 2025 Year 07 Month 14 Day
Anticipated trial start date - 2025 Year 10 Month 03 Day
Last follow-up date - 2025 Year 10 Month 10 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070462
Disclaimer: Curated by HT Syndication.